influenza (flu)

Flu’s “hidden target” may lead to universal vaccine: study

Researchers at Vanderbilt University Medical Center and the Scripps Research Institute have discovered a “hidden target” on the surface of the hypervariable influenza A virus that could lead to better ways to prevent and treat the flu.

Flu vaccine participation rate reaches 98 percent

Ninety-eight percent of Vanderbilt University Medical Center employees have received a flu vaccine in each of the past three years, according to data collected by the Vanderbilt Occupational Health Clinic, which oversees the employee flu vaccine program.

Designing antibodies to fight the flu

Vanderbilt investigators said their work shows that computational design can improve the ability of naturally occurring antibodies to recognize different flu strains and may hasten the development of more effective flu therapies and vaccines.

Mascots get flu shots in VUMC “anti-viral” video

Even canines, chickens and sabre-tooth tigers need protection

Team seeks to identify immune response to influenza

Vanderbilt researchers, as part of the International Human Vaccines Project, are searching for the key to lasting protection against influenza by examining naturally protecting cells found in bone marrow.

Symposium to focus on prospects for a universal flu vaccine

Internationally known vaccine experts including Vanderbilt University’s James Crowe Jr., MD, will speak next month at a symposium in Nashville on prospects for a universal flu vaccine.

1 2 3 4 5 6 10